Forestar Group - FOR Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Forestar Group in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" FOR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FOR, but not buy additional shares or sell existing shares.
View FOR analyst ratings or view top-rated stocks.

3 Wall Street analysts have issued 1-year price targets for Forestar Group's stock. Their FOR share price forecasts range from $13.50 to $24.00. On average, they expect the company's stock price to reach $18.63 in the next twelve months. This suggests a possible upside of 24.9% from the stock's current price.
View analysts price targets for FOR or view top-rated stocks among Wall Street analysts.

Forestar Group's stock was trading at $15.41 at the start of the year. Since then, FOR stock has decreased by 3.2% and is now trading at $14.91.
View the best growth stocks for 2023 here.

Forestar Group saw a decrease in short interest in the month of January. As of January 15th, there was short interest totaling 280,700 shares, a decrease of 5.4% from the December 31st total of 296,800 shares. Based on an average trading volume of 114,200 shares, the days-to-cover ratio is currently 2.5 days. Approximately 1.6% of the company's stock are short sold.
View Forestar Group's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 20th 2023.
View our FOR earnings forecast.

Forestar Group Inc. (NYSE:FOR) released its quarterly earnings results on Wednesday, November, 9th. The oil and gas exploration company reported $1.02 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.54. The oil and gas exploration company had revenue of $381.40 million for the quarter, compared to the consensus estimate of $279.50 million. Forestar Group had a net margin of 11.98% and a trailing twelve-month return on equity of 13.61%.

4 employees have rated Forestar Group Chief Executive Officer Jim DeCosmo on Glassdoor.com. Jim DeCosmo has an approval rating of 42% among the company's employees. This puts Jim DeCosmo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Forestar Group investors own include Boeing (BA), Citigroup (C), NVIDIA (NVDA), Toll Brothers (TOL), Enphase Energy (ENPH), Mastercard (MA), Micron Technology (MU), Nokia Oyj (NOK), Pfizer (PFE) and QUALCOMM (QCOM).

Forestar Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "FOR."

Forestar Group's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Assenagon Asset Management S.A. (0.32%) and New York State Teachers Retirement System (0.00%). Insiders that own company stock include Daniel C Bartok, GF (Rick) Ringler III, James Douglas Allen and Lisa H Jamieson.
View institutional ownership trends.

Shares of FOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of FOR stock can currently be purchased for approximately $14.91.

Forestar Group (NYSE:FOR) has a market capitalization of $742.07 million and generates $1.52 billion in revenue each year. The oil and gas exploration company earns $178.80 million in net income (profit) each year or $3.20 on an earnings per share basis.

The company employs 309 workers across the globe.

Forestar Group's mailing address is 2221 E. LAMAR BLVD. SUITE 790, ARLINGTON TX, 76006. The official website for the company is www.forestar.com. The oil and gas exploration company can be reached via phone at (817) 769-1860, via email at investorrelations@drhorton.com, or via fax at 302-636-5454.